Home > News > Too much, too soon
May 3rd, 2004
Too much, too soon
Vinod Khosla and Steve Jurvetson are venture capitalists with an abiding faith in nanotechnology. Yet they have adopted contrasting strategies in pursuit of profits from nanotech startups. Jurvetson's firm, Draper Fisher Jurvetson, has backed 15 nanotech companies, staking out the pole position in the sector among Sand Hill Road's venture capital establishment.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014